Clinical Trials Browser

Phase 2 × Cytokine Release Syndrome × Interleukin 1 Receptor Antagonist Protein × Clear all

NCT04150913 2025-11-25

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Phase 2 Completed

15 enrolled 17 charts

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Neurotoxicity Syndromes